Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx.
Target Oncol. 2019 Feb;14(1):33-38. doi: 10.1007/s11523-018-0613-y.
Target Oncol. 2019.
PMID: 30607698
Clinical Trial.
Overall Survival of Patients With ALK-Positive Metastatic Non-Small-Cell Lung Cancer in the Russian Federation: Nationwide Cohort Study.
Tsimafeyeu I, Moiseenko F, Orlov S, Filippova E, Belonogov A, Nebesnykh A, Khalimov A, Karabina E, Shikina V, Abdelgafur A, Statsenko G, Titova I, Isaichikov D, Makarnyaeva G, Mordovskiy A, Barkovskaya O, Smirnov A, Gikalo M, Savelov N, Kosov D, Imyanitov E, Demidova I, Tjulandin S.
Tsimafeyeu I, et al. Among authors: abdelgafur a.
J Glob Oncol. 2019 May;5:1-7. doi: 10.1200/JGO.19.00024.
J Glob Oncol. 2019.
PMID: 31095455
Free PMC article.
Item in Clipboard
Cite
Cite